p53 mutations are a common genetic finding in hepatocellular carcinoma
from areas of high aflatoxin exposure. Recent small studies have show
n that p53 gene mutations may be less common in areas with a low preva
lence of hepatocellular carcinoma such as Great Britain. The protein p
roduct of mutant p53 can be detected immunohistochemically because of
its longer half life in comparison with native protein. This study use
d a novel monoclonal antibody DO-7, raised against recombinant p53 and
effective in routinely processed biopsy specimen tissue, to detect th
e mutant protein in a series of 45 cases of hepatocellular carcinoma o
ccurring in white subjects resident in the United Kingdom. Focal nucle
ar labelling was seen in four cases (9%); surrounding cirrhotic tissue
in one of these was negative for p53 expression. This study shows tha
t p53 mutations are a rare event in hepatocarcinogenesis in Great Brit
ain, an area of low aflatoxin exposure, and supports the concept of ge
ographical variations in the cause and pathogenesis of hepatocellular
carcinoma.